Use of cell free DNA as a prognostic biomarker in non-small cell lung cancer patients with bone metastasis

Background:Non-small cell lung cancer (NSCLC) is difficult to treat when metastasis has occurred. This study explores the use of cell-free DNA in the clinical management of NSCLC patients who have ...